GGrantIndex
← Search

Core - Biostatistics

$1,325,954P30FY2007CANIH

Dana-Farber Cancer Inst, Boston MA

Investigators

Linked publications, trials & patents

Paper 39713466Paper 39666914Paper 39605676Paper 39593217Paper 39536083Paper 39532885Paper 39484503Paper 39389170Paper 39322760Paper 39168126Paper 39160372Paper 39107288Paper 39042477Paper 39025073Paper 39024561Paper 38996877Paper 38992034Paper 38979326Paper 38979245Paper 38942046Paper 38924531Paper 38889153Paper 38861327Paper 38815709Trial NCT03029325Trial NCT02627430Trial NCT02142803Trial NCT02097225Trial NCT02079740Trial NCT01940809Trial NCT01835184Trial NCT01822509Trial NCT01575522Trial NCT01434316Trial NCT01307631Trial NCT01283035Trial NCT01116648Trial NCT01026324Trial NCT00956163Trial NCT00888134Trial NCT00662506Trial NCT00622401Trial NCT00458978Trial NCT00458549Trial NCT00429910Trial NCT00400946Trial NCT00376480Trial NCT00357500Trial NCT00301093Trial NCT00126672Trial NCT00101075Trial NCT00098865Trial NCT00098514Trial NCT00096291Trial NCT00095927Trial NCT00095901Trial NCT00095875Trial NCT00095836Trial NCT00090857Trial NCT00084838Trial NCT00083031Trial NCT00079326Trial NCT00072436Trial NCT00069940Trial NCT00053976Trial NCT00052611Trial NCT00047294Trial NCT00047281Trial NCT00020670Trial NCT00020605Trial NCT00007917Trial NCT00006107Trial NCT00005988Trial NCT00005096Trial NCT00004180Trial NCT00004163Trial NCT00004070Trial NCT00003761Trial NCT00003744Trial NCT00003657Trial NCT00003200Trial NCT00003058Trial NCT00003045Patent 9512485Patent 7786269Patent 7396678Patent 7229755Patent 7048929Patent 6908617Patent 6479284Patent 6479281Patent 5861424Patent 5670530Patent 5618831Patent 5502214Patent 5360803Patent 4625014Patent 4618492Patent 4542225Patent 4035566

Abstract

The Program in Biostatistical Science fosters fundamental and targeted research into the mathematical and computational questions in statistical science that arise in cancer research. We believe that the strongest interaction between clinical, biological, population and statistical scientists occurs in an environment in which faculty statisticians both conduct research in statistical methodology and work closely with scientists from other disciplines. As a result, the program supports a wide range of interdisciplinary research and collaborative projects in which statisticians serve as principal or co-principal investigators and hold leadership roles in national and international clinical trials groups and population-based consortia. The specific aims of the program are: 1. To develop new methodology in statistical science and computational biology that responds to emerging areas of cancer research. This research includes methods for the analysis of genomic and molecular biology investigations of cancer, such as gene and protein expression arrays, along with methods for the design and analysis of modern clinical trials, screening studies, and observational and population-based studies and for investigations of genetic predisposition of diseases. 2. To develop statistical software and programming environments for the analysis of new genomic assays as they become available and are used in studies of cancer. 3. To provide training and research mentoring for students wishing to begin careers as statisticians in cancer research. Training of minority students is a major focus. There are approximately 610 cancer-related program member publications in the last grant period, with 14% of them being intra-programmatic, 50% of them being inter-programmatic, and 39% of them being interinstitutional. The Program in Biostatistical Science has 32 members from six institutions (HSPH, DFCI, MGH, BWH, BIDMC, HMS). These members are affiliated with two departments at HSPH (Biostatistics and Epidemiology) and four departments at HMS (Medicine, Health Care Policy, Pediatrics, Radiation Oncology). The total NCI and other peer reviewed support for the last budget year was $7,470,789.

View original record on NIH RePORTER →